XKRX:288330 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
2875.00
(-29.96%)
Apr 23
Business Description
Bridge Biotherapeutics Inc
ISIN : KR7288330004
Share Class Description:
XKRX:288330: Ordinary SharesCompare
Compare
Traded in other countries / regions
288330.Korea IPO Date
2019-12-20Description
Bridge Biotherapeutics Inc is a drug research and development company. It operates in the pharmaceutical and bio industry. The company has two pipeline clinical-stage products namely, BBT-401 and BBT-877.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.69 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -4.32 | |||||
| Beneish M-Score | 11.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -75.6 | |||||
| 3-Year EBITDA Growth Rate | -26.1 | |||||
| 3-Year EPS without NRI Growth Rate | -24.3 | |||||
| 3-Year FCF Growth Rate | -31.4 | |||||
| 3-Year Book Growth Rate | -37.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.74 | |||||
| 9-Day RSI | 22.75 | |||||
| 14-Day RSI | 31.86 | |||||
| 6-1 Month Momentum % | -14.52 | |||||
| 12-1 Month Momentum % | -61.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.09 | |||||
| Quick Ratio | 2.09 | |||||
| Cash Ratio | 1.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.7 | |||||
| Shareholder Yield % | -4.62 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.33 | |||||
| Operating Margin % | -40349.29 | |||||
| Net Margin % | -42320.9 | |||||
| FCF Margin % | -32144.19 | |||||
| ROE % | -118.06 | |||||
| ROA % | -91.57 | |||||
| ROIC % | -290.78 | |||||
| ROC (Joel Greenblatt) % | -1163.25 | |||||
| ROCE % | -110.59 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 573.85 | |||||
| PB Ratio | 3.74 | |||||
| Price-to-Tangible-Book | 4.93 | |||||
| EV-to-EBIT | -1.24 | |||||
| EV-to-EBITDA | -1.29 | |||||
| EV-to-Revenue | 524.1 | |||||
| EV-to-FCF | -2.97 | |||||
| Price-to-Net-Current-Asset-Value | 10.07 | |||||
| Price-to-Net-Cash | 9.58 | |||||
| Earnings Yield (Greenblatt) % | -80.63 | |||||
| FCF Yield % | -47.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bridge Biotherapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 100 | ||
| EPS (TTM) (â‚©) | -2060 | ||
| Beta | 1.63 | ||
| Volatility % | 85.06 | ||
| 14-Day RSI | 31.86 | ||
| 14-Day ATR (â‚©) | 625.473284 | ||
| 20-Day SMA (â‚©) | 5177.75 | ||
| 12-1 Month Momentum % | -61.49 | ||
| 52-Week Range (â‚©) | 2450 - 9540 | ||
| Shares Outstanding (Mil) | 23.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bridge Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bridge Biotherapeutics Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bridge Biotherapeutics Inc Frequently Asked Questions
What is Bridge Biotherapeutics Inc(XKRX:288330)'s stock price today?
The current price of XKRX:288330 is â‚©2875.00. The 52 week high of XKRX:288330 is â‚©9540.00 and 52 week low is â‚©2450.00.
When is next earnings date of Bridge Biotherapeutics Inc(XKRX:288330)?
The next earnings date of Bridge Biotherapeutics Inc(XKRX:288330) is .
Does Bridge Biotherapeutics Inc(XKRX:288330) pay dividends? If so, how much?
Bridge Biotherapeutics Inc(XKRX:288330) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers